Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.34

+0.00 (+1.44%)

As of Aug 15, 2:08 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +6,624.6% upside

Low Target $15.42

Average Target $22.81

High Target $25.92

Current Price $0.34

Current
$0.34

Target
$22.81

$15.42 $22.81 avg $25.92

Scenario Analysis

Bear Case

$15.42

4,446.0%

Low target

Base Case

$22.81

+6,624.6%

Avg target

Bull Case

$25.92

+7,541.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.58

-78.5% from high

52-Week Low

$0.30

+11.9% from low

Target vs 52W High

$22.81

+1,343.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%